Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Roche, Global Fund to Build Local Diagnostic Processes

Transporting HIV tests

The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes

Intl. Team Studying Antibiotic Overuse in Pigs

Two piglets

Researchers in Europe and the U.S. are investigating gut processes in pigs to reduce antibiotics commonly used against infections, a source of antibiotic resistance. . . . → Read More: Intl. Team Studying Antibiotic Overuse in Pigs

Hydrogel Shown to Boost Beneficial Gut Microbes

Gut microbes

Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health. . . . → Read More: Hydrogel Shown to Boost Beneficial Gut Microbes

Ginkgo Acquires Bayer Agricultural Biologics Technology

Iowa cornfield

Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology

Trial Begins Testing Crispr Gut Microbiome Therapy

E. coli

A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy

Biotech Start-Up Begins Longevity Therapy Work

Older couple

A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process. . . . → Read More: Biotech Start-Up Begins Longevity Therapy Work

Preclinical Tests Show Antibody Stops Covid-19 Variants

Human B-cell

Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants

Biotech Converting CO2 to Food Components Raises $7M

CO2 molecule model

A start-up company creating a process to convert carbon dioxide into food protein elements with microorganisms is raising $7 million in seed funds. . . . → Read More: Biotech Converting CO2 to Food Components Raises $7M

AI-Aided Disease Mgmt App Raises $3.8M in Seed Funds

Artificial intelligence graphic

A company creating a mobile app using artificial intelligence to help people manage their chronic diseases raised $3.8 million in seed funding. . . . → Read More: AI-Aided Disease Mgmt App Raises $3.8M in Seed Funds

Patent Board Rules for Broad Inst. in Crispr Case

Crispr graphic

A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells. . . . → Read More: Patent Board Rules for Broad Inst. in Crispr Case